JEMPERLI

Google image searchProduct monograph

Active ingredient

dostarlimab, 50 MG/ML

DIN: 02523434

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: GLAXOSMITHKLINE INC

Date: 22-FEB-2022

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FF — PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors (ATC, ATC/DDD)
• L01FF07 — DOSTARLIMAB (ATC/DDD)

Reference brand drug: Jemperli

External Links for Jemperli

Search on Google

• Jemperli side effects
• Jemperli dosage
• dostarlimab side effects
• dostarlimab dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find jemperli photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.